Trinity Biotech plc
Trinity Biotech plc, a leading player in the biotechnology sector, is headquartered in Ireland (IE) and operates extensively across Europe, the Americas, and Asia. Founded in 1992, the company has established itself as a pioneer in the development and manufacturing of diagnostic products, particularly in the fields of infectious diseases, diabetes, and autoimmune disorders. Trinity Biotech's core offerings include a diverse range of diagnostic tests and instruments, renowned for their accuracy and reliability. The company’s commitment to innovation has led to significant milestones, including the introduction of cutting-edge point-of-care testing solutions. With a strong market position, Trinity Biotech is recognised for its contributions to improving patient outcomes and advancing healthcare diagnostics globally.
DitchCarbon Score
How does Trinity Biotech plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Trinity Biotech plc's score of 18 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Trinity Biotech plc's reported carbon emissions
Trinity Biotech plc, headquartered in Ireland (IE), currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. Additionally, the company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. In the absence of specific emissions data, it is essential to note that many companies in the biotechnology sector are increasingly focusing on sustainability and reducing their carbon footprints. This trend often includes setting ambitious targets for emissions reductions and implementing initiatives aimed at minimising environmental impact. As such, Trinity Biotech may be expected to align with industry standards in addressing climate change, although specific commitments or initiatives have not been disclosed at this time.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Trinity Biotech plc is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
